Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pims Inc. (347770:KRX), powered by AI.
Pims Inc. is currently trading at ₩1,782. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pims Inc. on Alpha Lenz.
Pims Inc.'s P/E ratio is -5.0.
“Pims Inc. trades at a P/E of -5.0 (undervalued) with modest ROE of -16.3%.”
Ask for details →Pims Inc. is a company known for its pivotal role in the pharmaceutical and biotechnology sector. It specializes in the development and commercialization of innovative therapeutics aimed at addressing unmet medical needs. The primary function of Pims Inc. is to conduct extensive research and development to create advanced biologic drugs and specialty pharmaceuticals that target chronic and serious health conditions. Noteworthy for its robust pipeline of products in various stages of clinical trials, Pims Inc. significantly impacts the healthcare industry by bringing forward leading-edge treatments. Its operations extend to global markets, reinforcing its importance in not only advancing medical sciences but also contributing to healthcare accessibility. As a major player within the life sciences industry, Pims Inc. is instrumental in driving technological advancements and health-centric innovations, supported by strategic partnerships and collaborations with research institutions worldwide. Its contributions facilitate the progression of medicine, offering substantial value to shareholders and the broader community focused on improving patient outcomes.
“Pims Inc. trades at a P/E of -5.0 (undervalued) with modest ROE of -16.3%.”
Ask for details →Pims Inc. (ticker: 347770) is a company listed on KRX in the Technology sector (Electronic Components). It has approximately 195 employees. Market cap is $40.7B.
The current price is ₩1,782 with a P/E ratio of -4.95x and P/B of 0.87x.
ROE is -16.27% and operating margin is -9.65%. Annual revenue is $63.4B.